Loading insider details...
Beta
Latest Form 4 (Aug 18, 2026): Exercise/Conversion of 32,710 ABBV shares, $2.58M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 18, 2026 | AbbVie Inc. (ABBV) | Exercise/Conversion | 32,710 | $2.58M |
| Mar 3, 2026 | AbbVie Inc. (ABBV) | Tax Withholding | 12,874 | $2.99M |
| Feb 20, 2026 | AbbVie Inc. (ABBV) | Grant/Award | 13,031 | n/a |
| Aug 7, 2025 | AbbVie Inc. (ABBV) | Sale | 3,234 | $641.2K |
| Mar 4, 2025 | AbbVie Inc. (ABBV) | Tax Withholding | 11,230 | $2.30M |
| Feb 18, 2025 | AbbVie Inc. (ABBV) | Grant/Award | 11,017 | n/a |
| Mar 22, 2024 | AbbVie Inc. (ABBV) | Sale | 21,082 | $3.72M |
| Mar 1, 2024 | AbbVie Inc. (ABBV) | Tax Withholding | 16,771 | $3.00M |
| Feb 20, 2024 | AbbVie Inc. (ABBV) | Grant/Award | 22,657 | n/a |
| Dec 28, 2023 | AbbVie Inc. (ABBV) | Sale | 2,912 | $450.5K |